{"asset":{"id":"d08ad902-ff91-4cb2-b374-8ce79fdaa251","symbol":"ABBV","name":"AbbVie","asset_type":"stock","exchange":"US","country":"US","currency":"USD","sector":"Health Care","industry":"Biotechnology","crypto_category":null,"coingecko_id":null,"is_active":true,"created_at":"2026-11-16T20:38:59.474331+00:00","updated_at":"2026-11-16T20:38:59.474331+00:00"},"latest_value_score":{"id":1,"asset_id":"d08ad902-ff91-4cb2-b374-8ce79fdaa251","score_date":"2026-11-18","value_score":42.737500000000004,"value_component":42.737500000000004,"quality_component":44.58216666666666,"risk_component":51.74999999999999,"valuation_status":"weak","quality_status":"weak","risk_status":"neutral","value_trap_flag":false,"margin_of_safety":null,"fair_value_low":null,"fair_value_mid":null,"fair_value_high":null,"score_breakdown":{"risk":{"leverage_score":0.5,"liquidity_score":0.05833333333333329,"volatility_score":1.0},"value":{"pb_score":1.0,"pe_score":0.0,"dividend_score":1.0,"ev_ebitda_score":0.10950000000000004},"quality":{"roe_score":0.0,"growth_score":0.6866666666666666,"margin_score":0.7832999999999999},"raw_metrics":{"beta":0.192,"ev_ebitda":18.467,"forward_pe":18.055525,"net_margin":0.15666,"trailing_pe":50.573402,"current_ratio":0.87,"price_to_book":-112.92712,"debt_to_equity":null,"dividend_yield":2.35,"revenue_growth":0.103,"operating_margin":0.36635,"return_on_equity":null}},"created_at":"2026-11-18T07:58:27.32786+00:00"},"latest_ranking":{"id":"07b39221-41cd-4c6f-9e3d-9793a87098b0","asset_id":"d08ad902-ff91-4cb2-b374-8ce79fdaa251","ranking_date":"2026-11-18","overall_score":51.30429166666667,"value_component":42.737500000000004,"quality_component":44.58216666666666,"risk_component":48.25000000000001,"technical_component":75.5,"news_component":50.0,"opportunity_type":"watchlist","rank":74,"rationale":{"news_bias":0.0,"technical":"Signal: add, confidence: 65.0","asset_type":"stock","components":{"news_component":50.0,"risk_component":48.25000000000001,"value_component":42.737500000000004,"quality_component":44.58216666666666,"technical_component":75.5,"value_trap_penalty_applied":false},"news_strength":0.29500000000000004,"value_trap_flag":false,"articles_analyzed":10},"created_at":"2026-11-18T08:06:21.888957+00:00","updated_at":"2026-11-18T08:06:21.888957+00:00"},"latest_signal":{"id":"6974d00b-57e7-4743-9224-5f260c690212","asset_id":"d08ad902-ff91-4cb2-b374-8ce79fdaa251","signal_date":"2026-11-18T07:56:37.019606+00:00","signal_type":"tactical","action":"add","confidence":65.0,"entry_price":292.82000732421875,"entry_zone_low":285.46643720354353,"entry_zone_high":300.17357744489397,"stop_loss":278.1128670828683,"target_1":307.5271475655692,"target_2":314.8807176862444,"risk_reward_ratio":1.0,"position_size_pct":2.0,"time_horizon":"days_to_weeks","invalidation_level":278.1128670828683,"summary":"Fused signal based on technical setup and 10 recent news articles. News bias: 0.00, news strength: 0.30.","status":"active","created_at":"2026-11-18T07:06:15.470222+00:00","updated_at":"2026-11-18T07:56:37.019643+00:00","engine_version":null,"price_as_of":null,"price_fetched_at":null,"price_basis":null,"reference_price":null,"technical_score":null,"calculation_metadata":null},"signal_reasons":[{"id":88,"signal_id":"6974d00b-57e7-4743-9224-5f260c690212","category":"news","reason":"Recent news is neutral or insufficiently influential | Technical confidence: 65.00 | News bias: 0.00 | News strength: 0.30 | Fused confidence: 65.00 | Recent articles analyzed: 10 | Previous technical action: add","impact":"neutral","weight":1.0,"source":"Finnhub news ingestion; 10 articles analyzed","created_at":"2026-11-18T07:56:37.322159+00:00"},{"id":2,"signal_id":"6974d00b-57e7-4743-9224-5f260c690212","category":"technical","reason":"Η τιμή είναι πάνω από SMA20 και SMA50 — bullish trend.","impact":"positive","weight":15,"source":"tactical_engine_v1","created_at":"2026-11-18T07:06:15.59027+00:00"}],"recent_news":[{"id":24,"asset_id":"d08ad902-ff91-4cb2-b374-8ce79fdaa251","published_at":"2026-11-18T01:47:02+00:00","title":"Johnson & Johnson vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy for 2027?","url":"https://finnhub.io/api/news?id=827371972d261b4f3a9da2cb123267dcf0ecf42f9b6ae0b713fbaf1f8e8587a9","source":"Yahoo","category":"company_news","sentiment":0.0,"impact_score":0,"relevance_score":1.0,"summary":"Johnson & Johnson's diversified MedTech and pharma mix faces off against Vertex's cystic fibrosis dominance, but their valuation gap tells a story worth weighing.","created_at":"2026-11-18T07:12:12.171944+00:00"},{"id":25,"asset_id":"d08ad902-ff91-4cb2-b374-8ce79fdaa251","published_at":"2026-11-17T19:03:00+00:00","title":"How Did AbbVie's Neuroscience Franchise Perform in Q3?","url":"https://finnhub.io/api/news?id=0d6f64642075a9d098b2f36519d660d9efc8294dd21abc5fa2da5928b59f1c5f","source":"Yahoo","category":"company_news","sentiment":0.3333333333333333,"impact_score":1,"relevance_score":1.0,"summary":"ABBV's neuroscience franchise delivers 19.5% operational sales growth in Q3, prompting the company to raise its 2026 segment sales outlook to $13 billion.","created_at":"2026-11-18T07:12:12.276658+00:00"},{"id":26,"asset_id":"d08ad902-ff91-4cb2-b374-8ce79fdaa251","published_at":"2026-11-17T18:30:50+00:00","title":"Invest $200,000 in These 5 Dividend Stocks to Fund Your Retirement Income","url":"https://finnhub.io/api/news?id=ba0f9f80f39b7d6c01e9032725995faeb41da7204986e0b1924958e1d10e7680","source":"Yahoo","category":"company_news","sentiment":0.0,"impact_score":0,"relevance_score":1.0,"summary":"Selling shares in a down market can turn a retirement plan into a slow leak. Five dividend payers across five sectors aim to cover the bills instead, but one of them carries $166.2B of debt, and each one hides a risk worth knowing first.","created_at":"2026-11-18T07:12:12.380094+00:00"},{"id":27,"asset_id":"d08ad902-ff91-4cb2-b374-8ce79fdaa251","published_at":"2026-11-17T17:02:00+00:00","title":"Drug and Gene Delivery Devices - Global Strategic Business Report 2026: Capitalize on 8.1% CAGR to Secure the $1.2 Billion Market by 2032 as AbbVie, Moderna, Pfizer and Novartis Accelerate","url":"https://finnhub.io/api/news?id=f6160d6f1a76ed6f278c3fda312f99421031278e526ab47a4115947c9ad355da","source":"Yahoo","category":"regulatory","sentiment":0.0,"impact_score":0,"relevance_score":1.0,"summary":"Boost ROI through next-gen delivery platforms that differentiate biologics, extend patent life, enable precision therapies and meet demand for non-invasive, connected care.Dublin, Nov. 17, 2026 (GLOBE NEWSWIRE) -- \"Drug and Gene Delivery Devices - Global Strategic Business Report 2026\" has been added to ResearchAndMarkets.com's offering. The global drug and gene delivery devices market was valued at US$708.5 million in 2025 and is projected to reach US$1.2 billion by 2032, expanding at a compoun","created_at":"2026-11-18T07:12:12.480981+00:00"},{"id":28,"asset_id":"d08ad902-ff91-4cb2-b374-8ce79fdaa251","published_at":"2026-11-17T16:53:51+00:00","title":"Cathie Wood and 9 Other Big Funds Bought Eli Lilly Last Quarter, While 18 Sold. Who’s Right?","url":"https://finnhub.io/api/news?id=4b1c0a70709ba3608d9c168a208e16d4c7616e7a4f15a4a5f27aa4777bb456ef","source":"Yahoo","category":"earnings","sentiment":0.0,"impact_score":0,"relevance_score":1.0,"summary":"Key TakeawaysOf 456 big funds that have filed 13Fs for the quarter ended Sept. 30, 10 bought Eli Lilly and 18 sold.","created_at":"2026-11-18T07:12:12.586967+00:00"},{"id":29,"asset_id":"d08ad902-ff91-4cb2-b374-8ce79fdaa251","published_at":"2026-11-17T16:43:00+00:00","title":"J&J to Acquire Ollin Biosciences: A Look at Its Recent Buyouts","url":"https://finnhub.io/api/news?id=9bf35b273d9e73a507f601833b4ed6ccbeb7298e219b04a2fc12fbb3e4a562bd","source":"Yahoo","category":"company_news","sentiment":0.0,"impact_score":0,"relevance_score":1.0,"summary":"J&J's $2.2 billion Ollin Biosciences deal adds a promising retinal disease candidate, building on acquisitions.","created_at":"2026-11-18T07:12:12.693262+00:00"},{"id":30,"asset_id":"d08ad902-ff91-4cb2-b374-8ce79fdaa251","published_at":"2026-11-17T16:15:50+00:00","title":"Forget SCHD: 4 Dividend Stocks Retirees Should Own Instead","url":"https://finnhub.io/api/news?id=ef861551bd5105a1bd2927cf849864516304f8a31d7a51ed62d49cae14cc34c0","source":"Yahoo","category":"company_news","sentiment":-0.3333333333333333,"impact_score":1,"relevance_score":1.0,"summary":"SCHD protects retirees from any single dividend cut, but its income has barely moved while living costs climb. Four blue-chip payers raise checks faster, and each one carries a risk that could undercut the pitch.","created_at":"2026-11-18T07:12:12.802246+00:00"},{"id":31,"asset_id":"d08ad902-ff91-4cb2-b374-8ce79fdaa251","published_at":"2026-11-17T16:13:44+00:00","title":"Can Regeneron Stock Hit $1,400?","url":"https://finnhub.io/api/news?id=47caeb09c3274548716f38b0f3b71837d3a307862c4d2e0438f7c2089bbf240f","source":"Yahoo","category":"company_news","sentiment":0.0,"impact_score":0,"relevance_score":1.0,"summary":"Today's big story: Could Nvidia Stock Fall 50%? Follow The Cash.","created_at":"2026-11-18T07:12:12.924382+00:00"},{"id":32,"asset_id":"d08ad902-ff91-4cb2-b374-8ce79fdaa251","published_at":"2026-11-17T16:13:40+00:00","title":"Should You Buy Pfizer Stock For Its Cash?","url":"https://finnhub.io/api/news?id=c9257373b28e5ffad36e2b2c12aa9642f465206b5d161e3749c32e731fda467a","source":"Yahoo","category":"company_news","sentiment":0.0,"impact_score":0,"relevance_score":1.0,"summary":"Today's big story: Could Nvidia Stock Fall 50%? Follow The Cash.","created_at":"2026-11-18T07:12:13.04432+00:00"},{"id":33,"asset_id":"d08ad902-ff91-4cb2-b374-8ce79fdaa251","published_at":"2026-11-17T15:00:03+00:00","title":"Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock","url":"https://finnhub.io/api/news?id=45231fd99e4352c94e94bc7be1ace7ea947c4414c2f4bf9871b879963f4b0355","source":"Yahoo","category":"company_news","sentiment":0.0,"impact_score":0,"relevance_score":1.0,"summary":"AbbVie (ABBV) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.","created_at":"2026-11-18T07:12:13.151945+00:00"}]}